Pan‑cancer analysis on the role of KMT2C expression in tumor progression and immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pan‑cancer analysis on the role of KMT2C expression in tumor progression and immunotherapy

Published:2024-07-19 Issue:3 Volume:28 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Cao Wei¹,Xie Yawen²,Cai Li²,Wang Mengqing²,Chen Zhuoying²,Wang Ziteng²,Xv Jiajia²,Wang Yuqing²,Li Rong²,Liu Xuesong²,Wang Wenliang³

Affiliation:

1. Department of Thoracic Surgery, Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230601, P.R. China

2. Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Medical University, Hefei, Anhui 230032, P.R. China

3. Institute of Clinical Immunology, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China

Publisher

Spandidos Publications

Reference66 articles.

1. Beyond immune checkpoint blockade: Emerging immunological strategies;Kubli;Nat Rev Drug Discov,2021

2. Immune checkpoint signaling and cancer immunotherapy;He;Cell Res,2020

3. A Highlight of the mechanisms of immune checkpoint blocker resistance;Huang;Front Cell Dev Biol,2020

4. A guide to cancer immunotherapy: From T cell basic science to clinical practice;Waldman;Nat Rev Immunol,2020

5. Advances in cancer immunotherapy 2019-latest trends;Kruger;J Exp Clin Cancer Res,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP